|
| | Issue Date | Title | Author(s) |
| 121 | 2013 | Novel 2-thiopyrimidine derivatives as CDK2 inhibitors: molecular modeling, synthesis, and anti-tumor activity evaluation | Fathalla, OAM; Ismail, MAH; Anwar, MM; Abouzid, Khaled ; Ramadan, AAK |
| 122 | 15-May-2008 | Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity | Abouzid, Khaled ; Bekhit, Salma A |
| 123 | 2020 | Novel Benzimidazole/Hydrazone Derivatives as Promising Anticancer Lead Compounds: Design, Synthesis, and Molecular Docking Study | Morcoss, Martha; Abdelhafez, El Shimaa; Abdel-Rahman, Hamdy; lhab Abdel Aziz Mohammed ; Abou El Ella, Dalal |
| 124 | 1-Feb-2024 | Novel indolinone-tethered benzothiophenes as anti-tubercular agents against MDR/XDR M. tuberculosis: Design, synthesis, biological evaluation and in vivo pharmacokinetic study | Eldehna, Wagdy M.; Mahmoud, Sally Tarek; Elshnawey, Esraa R.; Elsayed, Zainab M.; Majrashi, Taghreed A.; El-Ashrey, Mohamed K.; Rashed, Mahmoud; Hemeda, Loah R.; Shoun, Aly A.; Elkaeed, Eslam B.; El Hassab, Mahmoud A.; Abdel-Aziz, Marwa M.; Shahin, Mai I. |
| 125 | 1-Dec-2017 | Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity | Aly, Rasha M.; Serya, Rabah ; El-Motwally, Amira M.; Abbas, Safinaz; Abou El Ella, Dalal ; Esmat, Ahmed |
| 126 | 15-Jul-2018 | Novel series of 6-(2-substitutedacetamido)-4-anilinoquinazolines as EGFR-ERK signal transduction inhibitors in MCF-7 breast cancer cells | Ismail, Rania S M; Abou-Seri, Sahar M; Eldehna, Wagdy M; Ismail, Nasser S M; Elgazwi, Sara M; Ghabbour, Hazem A; Ahmed, Mahmoud Salama; Halaweish, Fathi T; Abou El Ella, Dalal |
| 127 | 15-Mar-2024 | Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells | Helmy, Sama W.A.; Abdel-Aziz, Amal Kamal ; Dokla, Eman M.E.; Ahmed, Tarek E.; Hatem, Yasmin; Abdel Rahman, Engy A.; Sharaky, Marwa; Shahin, Mai I. ; Elrazaz, Eman Z.; Serya, Rabah A.T.; Henary, Maged; Ali, Sameh S.; Abou El Ella, Dalal A. |
| 128 | 2011 | Optimization of Benzoisothiazole dioxide inhibitory activity of the NS5B polymerase of HCV genotype 4 using ligand-steered homological modeling, reaction-driven scaffold-hopping and Enovo workflow | Mahmoud, Amr Hamed; Abouzid, Khaled ; El Ella, Dalal Abd El Rahman Abou; Hamid Ismail, Mohamed Abdel |
| 129 | 2010 | Organic synthesis and biological evaluation of novel "3+1" mixed ligands of technetium-99m Gabapentin as receptor imaging agents | Amin, AM; Abouzid, Khaled ; Bayoumi, NA; Abd El-hamid, M |
| 130 | 1-Aug-2020 | Penicillin binding protein 2a: An overview and a medicinal chemistry perspective | Shalaby, Menna-Allah W; Dokla, Eman ; Serya, Rabah ; Khaled A M Abouzid |
| 131 | 1-Dec-2019 | Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer | Elmenier, Fatma M; Lasheen, Deena S. ; Khaled A M Abouzid |
| 132 | 1-Sep-2011 | Preparation of 99mTc-ceftazidime as a model of infection imaging agent | M. A. Motaleb; A. A. El Mohty; M. A. El Garhy; Mohamed abdel Hamid Ismail; Abouzid, Khaled ; Tamer M. Sakr |
| 133 | 2016 | Pyrazolo[3,4-d]pyrimidine based scaffold derivatives targeting kinases as anticancer agents | Ismail, Nasser S.M.; Ali, Eslam M.H.; Ibrahim, Diaa A.; Serya, Rabah A.T.; Abou El Ella, Dalal |
| 134 | Mar-2017 | Pyridazine Based Scaffolds as Privileged Structures in anti-Cancer Therapy | Jaballah, Maiy Youssef; Serya, Rabah Taha; Abouzid, Khaled |
| 135 | 1-Jan-2008 | Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity | Abouzid, Khaled ; Abdel Hakeem, Maha; Khalil, Omnya; Maklad, Yosria |
| 136 | 16-Aug-2024 | Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigation | El-Nagar, Mohamed K.S.; Shahin, Mai I. ; El-Behairy, Mohammed F.; Taher, Ehab S.; El-Badawy, Mohamed F.; Sharaky, Marwa; Abou El Ella, Dalal A.; Abouzid, Khaled A.M.; Adel, Mai |
| 137 | Sep-2018 | Pyrrolopyrimidine, A Multifaceted Scaffold in Cancer Targeted Therapy | Adel, Mai; Serya, Rabah A T; Lasheen, Deena S. ; Abouzid, Khaled |
| 138 | 1-Aug-2013 | Quinazoline and tetrahydropyridothieno[2,3-d]pyrimidine derivatives as irreversible EGFR tyrosine kinase inhibitors: Influence of the position 4 substituent | Hamed, Mostafa M.; Abou El Ella, Dalal ; Keeton, Adam B.; Piazza, Gary A.; Engel, Matthias; Hartmann, Rolf W.; Abadi, Ashraf H. |
| 139 | May-2016 | Quinoline-based small molecules as effective protein kinases inhibitors (Review) | Rasha M. Aly; Rabah A. T. Serya; Amira M. El-Motwally; Ghada H. Al-Ansary; Abou El Ella, Dalal |
| 140 | May-2016 | Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity | El Newahie, Aliya M S; Ismail, Nasser S M; Abou El Ella, Dalal ; Abouzid, Khaled |
